BioCentury | Dec 7, 2009
Finance

Ebb & Flow

...at the beginning of 2010. She was the co-founder and CEO of German biotools company Amaxa GmbH...
BioCentury | Dec 3, 2007
Company News

amaxa sales and marketing update

...two 96-well Shuttle Kits for high throughput DNA and siRNA transfection of mouse dendritic cells. amaxa GmbH...
BioCentury | Oct 15, 2007
Company News

amaxa, Promega deal

...The companies will combine amaxa's Nucleofactor siRNA transfection technology with Promega's ONE-Glo luciferase assay reagent system...
...cell-signaling events in stem cells, cancer cells and primary cells. Further terms were not disclosed. amaxa GmbH...
BioCentury | Jul 24, 2006
Company News

amaxa sales and marketing update

...amaxa launched its Nucleofector 96-well Shuttle System for high throughput transfection of primary cells. amaxa GmbH...
BioCentury | Jun 12, 2006
Company News

amaxa, Fisher sales and marketing update

...Inc. subsidiary (Lafayette, Co.) with amaxa's Nucleofector siRNA transfection technology. Further terms were not disclosed. amaxa GmbH...
BioCentury | Oct 3, 2005
Company News

amaxa, American Type Culture Collection deal

...American Type will supply amaxa with cell lines. amaxa plans to use the lines to develop...
...use the lines to develop and optimize protocols using its Nucleofector non-viral gene transfer technology. amaxa GmbH...
BioCentury | Aug 11, 2003
Company News

amaxa, Qiagen sales and marketing update

...amaxa's non-viral Nucleofector siRNA transfection technology with QIA's HPP (high performance purity) grade siRNA oligonucleotides. amaxa GmbH...
BioCentury | Aug 4, 2003
Financial News

Qiagen beats Street EPS

...for a variety of gene silencing experiments. Separately, QIA and amaxa (Cologne, Germany) will co-market amaxa's...
BioCentury | Feb 17, 2003
Company News

amaxa sales and marketing update

...technology for small interfering RNA (siRNA)-induced gene silencing in primary cells and hard-to-transfect cell lines. amaxa GmbH...
BioCentury | Oct 21, 2002
Company News

amaxa genomics news

...reduced its headcount to 80 from 100 in a move to reach profitability in 2003. amaxa...
...development and marketing of its Nucleofector technology for gene transfer into primary and hard-to-transfect cells. amaxa GmbH...
Items per page:
1 - 10 of 16
BioCentury | Dec 7, 2009
Finance

Ebb & Flow

...at the beginning of 2010. She was the co-founder and CEO of German biotools company Amaxa GmbH...
BioCentury | Dec 3, 2007
Company News

amaxa sales and marketing update

...two 96-well Shuttle Kits for high throughput DNA and siRNA transfection of mouse dendritic cells. amaxa GmbH...
BioCentury | Oct 15, 2007
Company News

amaxa, Promega deal

...The companies will combine amaxa's Nucleofactor siRNA transfection technology with Promega's ONE-Glo luciferase assay reagent system...
...cell-signaling events in stem cells, cancer cells and primary cells. Further terms were not disclosed. amaxa GmbH...
BioCentury | Jul 24, 2006
Company News

amaxa sales and marketing update

...amaxa launched its Nucleofector 96-well Shuttle System for high throughput transfection of primary cells. amaxa GmbH...
BioCentury | Jun 12, 2006
Company News

amaxa, Fisher sales and marketing update

...Inc. subsidiary (Lafayette, Co.) with amaxa's Nucleofector siRNA transfection technology. Further terms were not disclosed. amaxa GmbH...
BioCentury | Oct 3, 2005
Company News

amaxa, American Type Culture Collection deal

...American Type will supply amaxa with cell lines. amaxa plans to use the lines to develop...
...use the lines to develop and optimize protocols using its Nucleofector non-viral gene transfer technology. amaxa GmbH...
BioCentury | Aug 11, 2003
Company News

amaxa, Qiagen sales and marketing update

...amaxa's non-viral Nucleofector siRNA transfection technology with QIA's HPP (high performance purity) grade siRNA oligonucleotides. amaxa GmbH...
BioCentury | Aug 4, 2003
Financial News

Qiagen beats Street EPS

...for a variety of gene silencing experiments. Separately, QIA and amaxa (Cologne, Germany) will co-market amaxa's...
BioCentury | Feb 17, 2003
Company News

amaxa sales and marketing update

...technology for small interfering RNA (siRNA)-induced gene silencing in primary cells and hard-to-transfect cell lines. amaxa GmbH...
BioCentury | Oct 21, 2002
Company News

amaxa genomics news

...reduced its headcount to 80 from 100 in a move to reach profitability in 2003. amaxa...
...development and marketing of its Nucleofector technology for gene transfer into primary and hard-to-transfect cells. amaxa GmbH...
Items per page:
1 - 10 of 16